Under the settlement, Mainers who are uninsured or have commercial health insurance will be eligible to purchase monthly ...

Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...

South Africa's Competition Commission is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...

The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.

Collector M. Pradeep Kumar distributed the aids to the children. Diabetic patients were given insulin pens for both long-acting and ultra-short-acting insulin, insulators, and glucometers with 100 ...

FDA approves insulin-aspart-szjj as biosimilar for diabetes treatment On February 14, 2025, Sanofi-Aventis announced the FDA approval ... aspart (Novolog), the approval includes both pre-filled pens ...

Merilog 100units/mL is supplied as both a 10mL multi-dose vial as well as a 3mL single-patient-use prefilled pen. The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a ...

Sanofi licensed the antibody from Alopexx Pharmaceuticals, a precursor to the current biotech of the same name, in 2009 but faced challenges such as the slow enrollment (PDF) of a phase 2a trial.

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...